Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla

被引:45
作者
Cserni, G [1 ]
机构
[1] Univ Szeged, Bacs Kiskun Cty Teaching Hosp, H-6000 Kecskemet, Hungary
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2001年 / 27卷 / 06期
关键词
breast cancer; axillary dissection; sentinel lymph-node metastasis; non-sentinel lymph-node metastases;
D O I
10.1053/ejso.2001.1138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Histopathological factors may help identifying a subgroup of breast cancer patients with metastases confined to the sentinel lymph nodes (SLNs). Methods: A retrospective analysis was carried out on I I I tumours successfully mapped with Patent blue, 69 of which had SLN metastases. Results: Multivariate analysis revealed that SLN metastases situated in the sinuses and a small tumour size are the two most important predictors of involvement of only one SLN. The metastasis size and a small tumour size were found important in the model discriminating between tumours with metastases to SLNs only and those with non-SLN involvement. Classification of tumours with only one SLN metastasis and those with a multinodal involvement resulted in a smaller error rate, falsely classified as lesser nodal involvement. Patients with tumours <1.8 cm and metastatic to the sinuses of a single SLN had a low probability of non-SLN metastasis, and might be candidates for axillary sparing after a positive SLN biopsy. Conclusions: Further investigations are required to assess the validity of such predictive models for the identification of patients with no metastases beyond the SLN. Axillary treatment must remain the rule until predictive models of non-SLN involvement are fully validated. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:532 / 538
页数:7
相关论文
共 46 条
  • [1] Allred DC, 1999, CANCER-AM CANCER SOC, V86, P905, DOI 10.1002/(SICI)1097-0142(19990915)86:6<905::AID-CNCR1>3.3.CO
  • [2] 2-B
  • [3] American Joint Committee on Cancer, 1997, AJCC CANC STAG MAN, P171
  • [4] Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO
  • [5] 2-Y
  • [6] The role of sentinel lymph node biopsy in breast cancer
    Bass, SS
    Cox, CE
    Ku, NN
    Berman, C
    Reintgen, DS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (02) : 183 - 194
  • [7] Sentinel node biopsy: a revolution in the surgical management of breast cancer?
    Beechey-Newman, N
    [J]. CANCER TREATMENT REVIEWS, 1998, 24 (03) : 185 - 203
  • [8] Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
    Borgstein, P
    Pijpers, R
    Comans, EF
    van Diest, PJ
    Boom, RP
    Meijer, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) : 275 - 283
  • [9] Predicting axillary lymph node metastases in breast carcinoma patients
    Choong, PL
    deSilva, CJS
    Dawkins, HJS
    Sterrett, GF
    Robbins, P
    Harvey, JM
    Papadimitriou, J
    Attikiouzel, Y
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (02) : 135 - 149
  • [10] Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis
    Chu, KU
    Turner, RR
    Hansen, NM
    Brennan, MB
    Giuliano, AE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) : 756 - 761